Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays

Fertility and Sterility

Volumn 87, Issue 5, 2007, Pages 1166-1172

  Malik, Minnie ^a   Catherino, William H ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

actin; biomarkers; Leiomyoma; microarray; myometrium; primary cultures; RT PCR; Western blot

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CYTOCHROME P450; TRANSFORMING GROWTH FACTOR BETA3; VERSICAN;

ARTICLE; CELL CULTURE; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; IN VITRO STUDY; LEIOMYOMA; MICROARRAY ANALYSIS; MYOMETRIUM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE; TUMOR CELL CULTURE; UNIVERSITY HOSPITAL;

CELL CULTURE TECHNIQUES; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; LEIOMYOMA; MYOMETRIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 34247523721     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.08.111     Document Type: Article

References (33)

1. Baird D.D. Invited commentary: uterine leiomyomata-we know so little but could learn so much. Am J Epidemiol 159 (2004) 124-126
2. Cramer S.F., and Patel D. The frequency of uterine leiomyomas. Am J Clin Pathol 94 (1990) 435-438
3. Buttram V.C., and Reiter R.C. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36 (1981) 433-445
4. Pokras R., and Hufnagel V.G. Hysterectomy in the United States, 1965-1984. Am J Public Health 78 (1988) 852-854
5. Catherino W.H., Prupas C., Tsibris J.C., Leppart P.C., Payson M., Nieman L.K., et al. Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology. Fertil Steril 80 (2003) 282-290
6. Catherino W.H., Leppert P.C., Stenmark M.H., Payson M., Potlog-Nahari C., Nieman L.K., et al. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer 40 (2004) 204-217
7. Leitao M.M., Soslow R.A., Nonaka D., Olshen A.B., Aghajanian C., Sabbatini P., et al. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 101 (2004) 1455-1462
8. Luo X., Ding L., Xu J., and Chegini N. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology 146 (2005) 1097-1118
9. Lee E.J., Kong G., Lee S.H., Rho S.B., Park C.S., Kim B.G., et al. Profiling of differentially expressed genes in human uterine leiomyomas. Int J Gynecol Cancer 15 (2005) 146-154
10. Walker C.L., Hunter D., and Everitt J. Uterine leiomyoma in the Eker rat: a unique model of important diseases of women. Genes Chromosomes Cancer 38 (2003) 349-356
11. Dallenbach F.D., and Thomas J.A. Experimentally induced myofibroblastic neoplasia in guinea pigs. Indian J Med Res 76 (1982) 272-280
12. Porter K.B., Tsibris J.C., Nicosia S.V., Murphy J.M., O'Brien W.F., Rao P.S., et al. Estrogen-induced guinea pig model for uterine leiomyomas: do the ovaries protect?. Biol Reprod 52 (1995) 824-832
13. Romangnolo B., Molina T., Leroy G., Blin C., Porteux A., Thomasset M., et al. Estradiol-dependent uterine leiomyomas in transgenic mice. J Clin Invest 98 (1996) 777-784
14. Webster M.A., Martin-Soudant N., Nepveu A., Cardiff R.D., and Muller W.J. The induction of uterine leiomyomas and mammary tumors in transgenic mice expressing polyomavirus (PyV) large T (LT) antigen is associated with the ability of PyV LT antigen to form specific complexes with retinoblastoma and CUTLI family members. Oncogene 16 (1998) 1963-1972
15. Nowak R.A., Rein M.S., Heffner L.J., Friedman A.J., and Tashjian A.H. Production of prolactin by smooth muscle cells cultured from human uterine fibroid tumors. J Clin Endocrinol Metab 76 (1992) 1308-1313
16. Bulun S.E., Simpson E.R., and Word R.A. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. J Clin Endocrinol Metab 78 (1993) 736-743
17. Kobayashi Y., Zhai Y.L., Iinuma M., Horiuchi A., Nikaido T., and Fujii S. Effects of a GnRH analogue on human smooth muscle cells cultured from normal myometrial and from uterine leiomyomal tissues. Mol Hum Reprod 3 (1997) 91-99
18. Horiuchi A., Nikaido T., Yoshizawa T., Itoh K., Kobayashi Y., Toki T., et al. HCG promotes proliferation of uterine leiomyomal cells more strongly than that of myometrial smooth muscle cells in vitro. Mol Hum Reprod 6 (2000) 523-528
19. Sumitani H., Shozu M., Segawa T., Murakami K., Yang H.-J., Shimada K., et al. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism. Endocrinology 141 (2000) 3852-3861
20. Sozen I., Olive D.L., and Arici A. Expression and hormonal regulation of monocyte chemotactic protein-1 in myometrium and leiomyomata. Fertil Steril 69 (1998) 1095-1102
21. Lee B.S., and Nowak R.A. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGFbeta3) and altered responses to the antiproliferative effects of TGF beta. J Clin Endocrinol Metab 86 (2001) 913-920
22. Chegini N., Tang X.-M., and Chunfeng M.A. Regulation of transforming growth factor-β1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab 84 (1999) 4138-4143
23. Arici A., and Sozen I. Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril 73 (2000) 1006-1011
24. Arici A., and Sozen I. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-β1 in human myometrium and leiomyoma. Am J Obstet Gynecol 188 (2003) 76-83
25. Luo X., Ding L., Xu J., and Chegini N. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-β. Endocrinology 146 (2004) 1097-1118
26. Catherino W.H., Salama A., Potlog-Nahari C., Leppert P., Tsibris J., and Segars J. Gene expression studies in leiomyomata: new directions for research. Semin Reprod Med 22 (2003) 83-90
27. Catherino W.H., and Segars J.H. Microarray analysis in leiomyomas: which gene list is the correct list?. Fertil Steril 80 (2003) 293-294
28. Okamoto O., Fujiwara S., Abe M., and Sato Y. Dermatopontin interacts with transforming growth factor beta and enhances its biological activity. Biochem J 337 (1999) 537-541
29. Tsibris J.C.M., Segars J.H., Coppola D., Mane S., Wilbanks G.D., O'Brien W.F., et al. Insights from gene arrays on the development and growth regulation of uterine leiomyomas. Fertil Steril 78 (2002) 114-121
30. Malik M., Mayers C., Leppert P.C., Segars J., and Catherino W.H. Molecular alterations in retinoic pathway of uterine leiomyomas (2005), National Institutes of Health, Bethesda, MD Presented at Advances in Leiomyoma Research: 2nd NIH International Congress. February 24-25
31. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45
32. Tsibris J.C., Porter K.B., Jazayeri A., Tzimas G., Nau H., Huang H., et al. Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium. Cancer Res 59 (1999) 5737-5744
33. Loy C.J., Evelyn S., Lim F.K., Liu M.H., and Yong E.L. Growth dynamics of human leiomyoma cells and inhibitory effects of the peroxisome proliferator-activated receptor-gamma ligand, pioglitazone. Mol Hum Reprod 11 (2005) 561-566